Commodore Capital LP 13D and 13G filings for Satsuma Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-16 4:10 pm Sale |
2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 0 0.000% |
-3,711,286 (Position Closed) |
Filing |
| 2022-02-14 4:10 pm Purchase |
2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,711,286 11.800% |
502,525 (+15.66%) |
Filing |
| 2021-10-19 5:20 pm Purchase |
2021-10-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,208,761 10.200% |
1,089,516 (+51.41%) |
Filing |
| 2021-03-15 07:57 am Purchase |
2021-03-03 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 2,119,245 6.700% |
2,119,245 (New Position) |
Filing |